In their retrospective series, Sathar et al [1] concluded that there is significant association between Helicobacter pyloriinfection (Hp-I) and portal hypertensive gastropathy (PHG) in cirrhotic patients, also related to PHG severity, thereby necessitating Hp eradication.Apart from PHG, hepatic encephalopathy (HE) is another complication of portal hypertension that remains a major cause of morbidity in cirrhotic patients [2]. HE encompasses a spectrum of neuropsychiatric disorders related to liver failure and the mechanisms responsible for the neurological alterations in HE begin to emerge [3].Hepatitis B (HBV) and C (HCV) infections are among the commonest causes of liver cirrhosis worldwide; Hp-I is strongly associated with HBV- and HCV-related cirrhosis in Europe; Hp-I is more common in cirrhotic patients with HE than in those without [4]; HE is not a fully reversible condition and the mechanism behind the lack of reversibility of the neurocognitive status despite the resolution of mental status changes is unclear [5]; and cognitive dysfunction is a factor associated with falls in cirrhotic patients, though further studies are warranted to address the mechanisms implicated in this predisposition and to design preventive strategies [5]. In this regard, Hp-I has been frequently detected in cognitive impairment and Alzheimer’s disease (AD) [6] and we found that Hp eradication may positively influence AD manifestations at five-year clinical endpoints [7], thereby supporting a role for this common infection in the pathobiology of the disease.Hp may be involved in the pathophysiology of both HE and post-HE persistent cognitive impairment by several mechanisms [7], including the release of proinflammatory/vasoactive substances, involved, through blood-brain-barrier disruption, in a number of vascular disorders including AD, which can lead to long-term neurologic deficits [4,5]. It is therefore important to know if the authors have considered the association between Hp-I, HE and/or post-HE cognitive impairment in their cirrhotic patients.